Abbott LaboratoriesABTNYSE
Loading
R&D Expenses Over TimeStable
Percentile Rank93
3Y CAGR+1.2%
5Y CAGR+4.1%
Year-over-Year Change
Research and development spending
3Y CAGR
+1.2%/yr
vs +5.7%/yr prior
5Y CAGR
+4.1%/yr
Consistent
Acceleration
-4.5pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $2.96B | +4.7% |
| 2024 | $2.82B | +3.8% |
| 2023 | $2.72B | -4.7% |
| 2022 | $2.85B | +4.2% |
| 2021 | $2.74B | +13.2% |
| 2020 | $2.42B | +0.4% |
| 2019 | $2.41B | +5.2% |
| 2018 | $2.29B | +7.4% |
| 2017 | $2.13B | +56.8% |
| 2016 | $1.36B | - |